Advertisement

Pediatric Radiology

, Volume 41, Issue 10, pp 1321–1325 | Cite as

Novel use of F-DOPA PET/CT imaging in a child with paraganglioma/pheochromocytoma syndrome

  • Daniel S. LevineEmail author
  • Daniel L. Metzger
  • Helen R. Nadel
  • Angelica Oviedo
  • Michael J. Adam
  • Erik Skarsgard
Technical Innovation

Abstract

We report the use of F-DOPA PET/CT imaging in the evaluation of a teenager with marked hypertension and right pararenal, left adrenal and left para-aortic mass lesions. The use of the modality for this clinical application has not been described previously within the pediatric imaging literature. The value of this technique relative to conventional imaging modalities is discussed and warrants consideration of its use, if available, for evaluating children with suspected paragangliomas/pheochromocytomas.

Keywords

F-DOPA PET/CT MIBG MRI Paraganglioma/pheochromocytoma syndrome 

Notes

Acknowledgement

The authors wish to thank Ms. J. Leggett, chief nuclear medicine technologist at British Columbia Children’s Hospital, for her help with image processing.

References

  1. 1.
    Muller U, Troidl C, Niemann S (2005) SDHC mutations in hereditary paraganglioma/pheochromocytoma. Fam Cancer 4:9–12PubMedCrossRefGoogle Scholar
  2. 2.
    Rao AB, Koeller KK, Adair CF (1999) From the archives of the AFIP. Paragangliomas of the head and neck: radiologic-pathologic correlation. Armed Forces Institute of Pathology. Radiographics 19:1605–1632PubMedGoogle Scholar
  3. 3.
    Badenhop RF, Cherian S, Lord RS et al (2001) Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss. Genes Chromosomes Cancer 31:255–263PubMedCrossRefGoogle Scholar
  4. 4.
    Imani F, Agopian VG, Auerbach MS et al (2009) 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas. J Nucl Med 50:513–519PubMedCrossRefGoogle Scholar
  5. 5.
    Wiseman GA, Pacak K, O’Dorisio MS et al (2009) Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med 50:1448–1454PubMedCrossRefGoogle Scholar
  6. 6.
    Brink I, Hoegerle S, Klisch J et al (2005) Imaging of pheochromocytoma and paraganglioma. Fam Cancer 4:61–68PubMedCrossRefGoogle Scholar
  7. 7.
    Hoegerle S, Nitzsche E, Altehoefer C et al (2002) Pheochromocytomas: detection with 18F DOPA whole body PET–initial results. Radiology 222:507–512PubMedCrossRefGoogle Scholar
  8. 8.
    Imani F, Agopian VG, Auerbach MS et al (2009) 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas. J Nucl Med 50:513–519PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Daniel S. Levine
    • 1
    Email author
  • Daniel L. Metzger
    • 2
  • Helen R. Nadel
    • 1
  • Angelica Oviedo
    • 3
  • Michael J. Adam
    • 4
  • Erik Skarsgard
    • 5
  1. 1.Department of Radiology & Nuclear Medicine, British Columbia Children’s HospitalUniversity of British ColumbiaVancouverCanada
  2. 2.Department of Pediatrics, Division of Endocrinology, British Columbia Children’s HospitalUniversity of British ColumbiaVancouverCanada
  3. 3.Department of Pathology, British Columbia Children’s HospitalUniversity of British ColumbiaVancouverCanada
  4. 4.Department of PET Chemistry, Tri-University Meson Facility (TRIUMF)University of British ColumbiaVancouverCanada
  5. 5.Department of Surgery, British Columbia Children’s HospitalUniversity of British ColumbiaVancouverCanada

Personalised recommendations